Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux.
暂无分享,去创建一个
[1] G. Szakács,et al. Characterization of the ATPase cycle of human ABCA1: implications for its function as a regulator rather than an active transporter. , 2001, Biochemical and biophysical research communications.
[2] R. Walczak,et al. Autoregulation of the Human Liver X Receptor α Promoter , 2001, Molecular and Cellular Biology.
[3] O. Francone,et al. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. , 2001, The Journal of clinical investigation.
[4] A. Vaughan,et al. ATP-binding Cassette Transporter A1 Mediates Cellular Secretion of α-Tocopherol* , 2001, The Journal of Biological Chemistry.
[5] Gaochao Zhou,et al. 27-Hydroxycholesterol Is an Endogenous Ligand for Liver X Receptor in Cholesterol-loaded Cells* , 2001, The Journal of Biological Chemistry.
[6] M. Hayden,et al. Human ABCA1 BAC Transgenic Mice Show Increased High Density Lipoprotein Cholesterol and ApoAI-dependent Efflux Stimulated by an Internal Promoter Containing Liver X Receptor Response Elements in Intron 1* , 2001, The Journal of Biological Chemistry.
[7] J. Upward,et al. An Overview of the Pharmacokinetics of Cilomilast (Ariflo®), a New, Orally Active Phosphodiesterase 4 Inhibitor, in Healthy Young and Elderly Volunteers , 2001, Journal of clinical pharmacology.
[8] A. Robichaud,et al. The next generation of PDE4 inhibitors. , 2001, Current opinion in chemical biology.
[9] H. Brewer,et al. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. , 2001, The Journal of clinical investigation.
[10] A. von Eckardstein,et al. ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte‐derived macrophages , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] S. Kliewer,et al. A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] W. Fung-Leung,et al. ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism. , 2001, Gastroenterology.
[13] J. Auwerx,et al. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Brown,et al. Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[15] A. Mendez,et al. Membrane Lipid Domains Distinct from Cholesterol/Sphingomyelin-Rich Rafts Are Involved in the ABCA1-mediated Lipid Secretory Pathway* , 2001, The Journal of Biological Chemistry.
[16] D. Mangelsdorf,et al. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Evans,et al. A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis , 2001 .
[18] M. Jaye,et al. PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway , 2001, Nature Medicine.
[19] J. Oram. Tangier disease and ABCA1. , 2000, Biochimica et biophysica acta.
[20] W. Wood,et al. Mesenchymal cells engulf and clear apoptotic footplate cells in macrophageless PU.1 null mouse embryos. , 2000, Development.
[21] Jean-Marc A. Lobaccaro,et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ , 2000 .
[22] D. Mangelsdorf,et al. Role of LXRs in control of lipogenesis. , 2000, Genes & development.
[23] R. Lawn,et al. ABCA1 Is the cAMP-inducible Apolipoprotein Receptor That Mediates Cholesterol Secretion from Macrophages* , 2000, The Journal of Biological Chemistry.
[24] P. Edwards,et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] G. Schmitz,et al. ABC transporters in cellular lipid trafficking , 2000, Current opinion in lipidology.
[26] J. Genest,et al. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations. , 2000, Atherosclerosis.
[27] J. Mcneish,et al. The Correlation of ATP-binding Cassette 1 mRNA Levels with Cholesterol Efflux from Various Cell Lines* , 2000, The Journal of Biological Chemistry.
[28] A. Tall,et al. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. , 2000, The Journal of biological chemistry.
[29] P. A. Peterson,et al. Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency. , 2000, The American journal of pathology.
[30] D. Mangelsdorf,et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. , 2000, Science.
[31] R. Lawn,et al. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. , 2000, Biochemical and biophysical research communications.
[32] A. Horwitz,et al. Identification of cAMP analogue inducible genes in RAW264 macrophages. , 2000, Biochimica et biophysica acta.
[33] M. Freeman,et al. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size. , 2000, Journal of lipid research.
[34] P. Borst,et al. ABC transporters in lipid transport. , 2000, Biochimica et biophysica acta.
[35] Yannick Hamon,et al. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. , 2000, Nature Cell Biology.
[36] D. Mangelsdorf,et al. Human White/Murine ABC8 mRNA Levels Are Highly Induced in Lipid-loaded Macrophages , 2000, The Journal of Biological Chemistry.
[37] M. Giovannoni,et al. Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologies. , 2000, European journal of medicinal chemistry.
[38] C. Gabel,et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Oram,et al. Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol. , 2000, Atherosclerosis.
[40] J. Beavo,et al. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. , 2000, Current opinion in cell biology.
[41] T. Langmann,et al. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice , 2000, Nature Genetics.
[42] C. Sensen,et al. Mutations in the ABC 1 gene in familial HDL deficiency with defective cholesterol efflux , 1999, The Lancet.
[43] A. Vaughan,et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. , 1999, The Journal of clinical investigation.
[44] T. Langmann,et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.
[45] J. Piette,et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.
[46] C. Sensen,et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.
[47] M. Torrisi,et al. The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. , 1999, Molecular biology of the cell.
[48] D. Williams,et al. Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP. , 1999, Biochimica et biophysica acta.
[49] I. Goldstein,et al. Sildenafil Citrate, a Selective Phosphodiesterase Type 5 Inhibitor: Research and Clinical Implications in Erectile Dysfunction , 1999, Trends in Endocrinology & Metabolism.
[50] S. Christensen,et al. 1,4-Cyclohexanecarboxylates: potent and selective inhibitors of phosophodiesterase 4 for the treatment of asthma. , 1998, Journal of medicinal chemistry.
[51] T. Torphy. Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. , 1998, American journal of respiratory and critical care medicine.
[52] S. Christensen,et al. SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions. , 1998, The Journal of pharmacology and experimental therapeutics.
[53] A Rubartelli,et al. Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. , 1997, Blood.
[54] A. Wendel,et al. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor‐α release by PDE inhibitors , 1997, British journal of pharmacology.
[55] B. Verrier,et al. ABC1, an ATP Binding Cassette Transporter Required for Phagocytosis of Apoptotic Cells, Generates a Regulated Anion Flux after Expression in Xenopus laevis Oocytes* , 1997, The Journal of Biological Chemistry.
[56] M. Luciani,et al. The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. , 1996, The EMBO journal.
[57] J. Lenhard,et al. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells. , 1995, Molecular pharmacology.
[58] J. Slotte,et al. Cyclic AMP stimulates efflux of intracellular sterol from cholesterol-loaded cells. , 1993, The Journal of biological chemistry.
[59] N. Miller. High-density lipoprotein: a major risk factor for coronary atherosclerosis. , 1987, Bailliere's clinical endocrinology and metabolism.
[60] G. Miller,et al. PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.